fasenra - benralizumab injection, solution
(Benralizumab)Astrazeneca Pharmaceuticals Lp
Usage: Fasenra is used as add-on maintenance for severe eosinophilic asthma (adults and children 6+), to treat eosinophilic granulomatosis with polyangiitis (EGPA) in adults, and to treat hypereosinophilic syndrome (HES) in adults and children 12+.